BNP Paribas Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-368,011
Closed -$27.8M 2294
2026
Q1
$27.8M Sell
368,011
-272,172
-43% -$20.5M 0.03% 478
2025
Q4
$47.7M Sell
640,183
-1,051,114
-62% -$76.8M 0.05% 316
2025
Q3
$114M Sell
1,691,297
-41,372
-2% -$2.75M 0.3% 63
2025
Q2
$113M Sell
1,732,669
-941,883
-35% -$56.5M 0.28% 83
2025
Q1
$165M Buy
2,674,552
+302,075
+13% +$20M 0.44% 44
2024
Q4
$171M Sell
2,372,477
-94,411
-4% -$7.38M 0.42% 43
2024
Q3
$201M Buy
2,466,888
+195,285
+9% +$15.6M 0.5% 36
2024
Q2
$169M Buy
2,271,603
+87,176
+4% +$6.53M 0.44% 44
2024
Q1
$170M Buy
2,184,427
+338,212
+18% +$25.2M 0.45% 48
2023
Q4
$132M Sell
1,846,215
-88,978
-5% -$6.2M 0.37% 60
2023
Q3
$134M Sell
1,935,193
-425,237
-18% -$32.1M 0.41% 53
2023
Q2
$191M Sell
2,360,430
-57,414
-2% -$4.69M 0.59% 31
2023
Q1
$195M Sell
2,417,844
-137,050
-5% -$11M 0.68% 26
2022
Q4
$191M Sell
2,554,894
-265,286
-9% -$18.9M 0.68% 25
2022
Q3
$182M Sell
2,820,180
-280,155
-9% -$19.4M 0.72% 25
2022
Q2
$215M Buy
3,100,335
+14,821
+0.5% +$1.1M 0.82% 21
2022
Q1
$237M Sell
3,085,514
-368,500
-11% -$26.5M 0.82% 20
2021
Q4
$264M Buy
3,454,014
+144,603
+4% +$10.6M 0.88% 19
2021
Q3
$244M Sell
3,309,411
-34,210
-1% -$2.57M 0.91% 17
2021
Q2
$223M Buy
3,343,621
+529,742
+19% +$35.4M 0.8% 22
2021
Q1
$209M Buy
2,813,879
+339,032
+14% +$25.7M 0.86% 18
2020
Q4
$180M Buy
2,474,847
+85,099
+4% +$6.01M 0.83% 18
2020
Q3
$159M Buy
2,389,748
+799,894
+50% +$50.6M 0.9% 16
2020
Q2
$90.6M Buy
1,589,854
+1,579,890
+15,856% +$77.5M 0.61% 28
2020
Q1
$350K Buy
9,964
+1,527
+18% +$72.7K ﹤0.01% 713
2019
Q4
$440K Buy
8,437
+2,061
+32% +$103K ﹤0.01% 728
2019
Q3
$322K Sell
6,376
-13,993
-69% -$689K ﹤0.01% 787
2019
Q2
$978K Sell
20,369
-227
-1% -$10.5K 0.01% 664
2019
Q1
$997K Sell
20,596
-6
-0% -$271 0.01% 698
2018
Q4
$833K Buy
20,602
+6,207
+43% +$255K 0.01% 729
2018
Q3
$590K Sell
14,395
-52,089
-78% -$2.11M ﹤0.01% 774
2018
Q2
$2.64M Buy
66,484
+7,321
+12% +$282K 0.02% 597
2018
Q1
$2.21M Buy
59,163
+48,159
+438% +$1.95M 0.02% 617
2017
Q4
$470K Buy
11,004
+1,161
+12% +$46.3K ﹤0.01% 819
2017
Q3
$361K Buy
9,843
+1,295
+15% +$52.3K ﹤0.01% 858
2017
Q2
$388K Sell
8,548
-927
-10% -$40.9K ﹤0.01% 849
2017
Q1
$403K Sell
9,475
-2,392
-20% -$97.5K ﹤0.01% 865
2016
Q4
$476K Sell
11,867
-53,493
-82% -$2.06M ﹤0.01% 862
2016
Q3
$2.54M Sell
65,360
-12,255
-16% -$463K 0.02% 655
2016
Q2
$2.69M Buy
77,615
+8,078
+12% +$280K 0.02% 631
2016
Q1
$2.4M Buy
69,537
+8,038
+13% +$280K 0.02% 638
2015
Q4
$2.38M Buy
61,499
+8,868
+17% +$345K 0.02% 626
2015
Q3
$2.06M Buy
52,631
+12,731
+32% +$505K 0.02% 661
2015
Q2
$1.52M Buy
39,900
+27,285
+216% +$955K 0.01% 773
2015
Q1
$417K Buy
+12,615
New +$387K ﹤0.01% 941

Other funds holding HOLX

BNP Paribas Asset Management's HOLX Position: Q2 2026 in Review

BNP Paribas Asset Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 368,011 shares — an estimated $27.8M sold.

BNP Paribas Asset Management first reported a position in HOLX in Q1 2015 and held it in 45 quarters. The position peaked at $264M in Q4 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • BNP Paribas Asset Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • BNP Paribas Asset Management sold 368,011 Hologic shares in Q2 2026, an estimated $27.8M.
  • BNP Paribas Asset Management first reported a position in Hologic in Q1 2015 and held it in 45 quarters.
  • BNP Paribas Asset Management's Hologic position peaked at $264M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.